Marketing-authorisation holder · Italy
Recordati Industria Chimica E Farmaceutica S.P.A. in Breve Recordati S.P.A.
50 medicines in 6 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Italy
50 medicines in 6 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 50
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALOVEXLABIALEMatita cutanea | Aciclovir | Italy | Authorised | |
| ALPROSTARPolvere per soluzione per infusione endovenosa | Alprostadil | Italy | Authorised | |
| ANTISPASMINA COLICACompressa rivestita | Belladonna, Papaverine | Italy | Authorised | |
| ATOVERCompressa rivestita con film | Enalapril, Lercanidipine | Italy | Authorised | |
| BELOKEN 1 mg/ml SOLUCION INYECTABLE5 mg · Solución inyectable | Metoprolol | Spain | Marketed | 1987 |
| BUPIVACAINA RECORDATISoluzione iniettabile | Bupivacaine | Italy | Authorised | |
| CARDIOVASCCompressa rivestita con film | Lercanidipine | Italy | Authorised | |
| CORIPRENCompressa rivestita con film | Enalapril | Italy | Authorised | |
| ELIGARDPolvere e solvente per soluzione iniettabile | Leuprorelin | Italy | Authorised | |
| Eligard 22,5 mg poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Leuprorelin | Netherlands | Authorised | 2005 |
| Eligard 22,5 mg prašak i otapalo za otopinu za injekcijuprašak i otapalo za otopinu za injekciju | Leuprorelin | Croatia | Marketed | 2021 |
| Eligard 45 mg poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Leuprorelin | Netherlands | Authorised | 2007 |
| Eligard 45 mg prašak i otapalo za otopinu za injekcijuprašak i otapalo za otopinu za injekciju | Leuprorelin | Croatia | Marketed | 2021 |
| Eligard 7,5 mg poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Leuprorelin | Netherlands | Authorised | 2005 |
| Eligard 7,5 mg prašak i otapalo za otopinu za injekcijuprašak i otapalo za otopinu za injekciju | Leuprorelin | Croatia | Not marketed | 2021 |
| ELIGARD SEMESTRAL 45 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE58,2 (JERINGA B mg · Polvo y disolvente para solución inyectable en jeringa precargada | Leuprorelin | Spain | Marketed | 2007 |
| ELIGARD SEMESTRAL 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE45 (JERINGA B) mg · Polvo y disolvente para solución inyectable en jeringa precargada | Leuprorelin | Spain | Marketed | 2024 |
| ELIGARD TRIMESTRAL 22,5 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE28,2-JERINGA B mg · Polvo y disolvente para solución inyectable en jeringa precargada | Leuprorelin | Spain | Marketed | 2005 |
| FALVINCapsula molle vaginale | Fenticonazole | Italy | Authorised | |
| GENURINCompressa rivestita | Flavoxate | Italy | Authorised | |
| IMIDAZYLCollirio, soluzione | Naphazoline, Tonzilamina | Italy | Authorised | |
| IMIDAZYL ANTISTAMINICOCollirio, soluzione | Naphazoline, Tonzilamina | Italy | Authorised | |
| INDUSILPolvere e solvente per soluzione orale | Cobamamide | Italy | Authorised | |
| ISOCEFGranulato per sospensione orale | Ceftibuten | Italy | Authorised | |
| LOCALYNGocce auricolari, soluzione | Fluocinolone acetonide, Neomycin | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 30 | 30 | 0 | CompaniesAll medicines |
| Spain | 9 | 6 | 3 | CompaniesAll medicines |
| Netherlands | 4 | 4 | 0 | CompaniesAll medicines |
| Croatia | 3 | 3 | 0 | CompaniesAll medicines |
| Romania | 3 | 0 | 3 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA; Gazzetta Ufficiale della Repubblica Italiana. Exact act IDs, publication dates, locators, URLs and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: Official administrative act text exclusion, Italian Law633/1941 Article5
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.